Surfactant proteins

SP-B Detection and Gene Expression in Chronic Rhinosinusitis
Bradford A. Woodworth, MD, Noam A. Cohen, MD, PhD, Rachel Wood, BS, Geeta Bhargave, BS, John E. Baatz, PhD, Rodney J. Schlosser, MD
http://www.uphs.upenn.edu

Lung surfactant proteins
Junqi Ding, Ivo Doudevski, Heidi E. Warriner, Timothy Alig, and Joseph A. Zasadzinski
http://macro.lsu.edu

Surfactants - Emulsifiers
http://class.fst.ohio-state.edu

The Extracellular Matrix
Jeff Davidson, Ph.D.
https://medschool.mc.vanderbilt.edu

Familial Pulmonary Disorders
Christine Garcia, MD, PhD
http://www3.utsouthwestern.edu

Inflammation and Innate Immunity
http://physio.ucsf.edu

Unfolding RXRalpha
Nancy Doremus and Jessie Dodge-Gittins
http://cbee.oregonstate.edu

285 Published articles on Surfactant proteins

1. Expression of acute-phase cytokines, surfactant proteins, and epithelial apoptosis in small airways of human acute respiratory distress syndrome.
2. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles.
3. Early expression of surfactant proteins D in Fusarium solani infected rat cornea.
4. Mechanisms of toxicity induced by SiO(2) nanoparticles of in vitro human alveolar barrier: effects on cytokine production, oxidative stress induction, surfactant proteins A mRNA expression and nanoparticles uptake.
5. Detection of surfactant proteins A, B, C, and D in human gingiva and saliva.
6. Surfactant proteins A and D in pulmonary diseases of preterm infants.
7. An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.
8. Immunohistochemical Staining of Surfactant Proteins A and B in Skin of Psoriatic Patients Before and After Narrow-Band UVB Phototherapy.
9. Latherin and other biocompatible surfactant proteins.
10. Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.
11. A combined action of pulmonary surfactant proteins SP-B and SP-C modulates permeability and dynamics of phospholipid membranes.
12. Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction.
13. Three-dimensional culture of an ovine pulmonary adenocarcinoma-derived cell line results in re-expression of surfactant proteins and Jaagsiekte sheep retrovirus.
14. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
15. Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study.
16. Surface-bound myeloperoxidase is a ligand for recognition of late apoptotic neutrophils by human lung surfactant proteins A and D.
17. Dispensability of surfactant proteins A and D in immune control of Mycobacterium tuberculosis infection following aerosol challenge of mice.
18. Surfactant proteins A and D in pregnancy and parturition.
19. The effect of interleukin-13 (IL-13) and interferon-γ (IFN-γ) on expression of surfactant proteins in adult human alveolar type II cells in vitro.
20. Importance of surfactant proteins B and D for the differential diagnosis of acute dyspnea.
21. Immunohistochemical evaluation of surfactant proteins and lymphocyte phenotypes in the lungs of cattle with natural tuberculosis.
22. Surfactant proteins and respiratory syncytial virus.
23. A young woman with interstitial pneumonia and coexisting deposition of surfactant proteins.
24. Reduced airway inflammation in CD26/DPP4-deficient F344 rats is associated with altered recruitment patterns of regulatory T cells and expression of pulmonary surfactant proteins.
25. Untapped therapeutic potential of surfactant proteins: is there a case for recombinant SP-D supplementation in neonatal lung disease?
26. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants.
27. Folding of lipid monolayers containing lung surfactant proteins SP-B(1-25) and SP-C studied via coarse-grained molecular dynamics simulations.
28. Hydrophobic surfactant proteins induce a phosphatidylethanolamine to form cubic phases.
29. Effects of nicotine on pulmonary surfactant proteins A and D in ovine lung epithelia.
30. The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms.
31. Lung surfactant proteins in the early human placenta.
32. Lung surfactant proteins A and D as pattern recognition proteins.
33. Collectins and fungal pathogens: roles of surfactant proteins and mannose binding lectin in host resistance.
34. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
35. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.
36. Human parotid and submandibular glands express and secrete surfactant proteins A, B, C and D.
37. Gender-related effects of prenatal administration of estrogen and progesterone receptor antagonists on VEGF and surfactant-proteins and on alveolarisation in the developing piglet lung.
38. Aberrant processing forms of lung surfactant proteins SP-B and SP-C revealed by high-resolution mass spectrometry.
39. Immunohistochemical detection of pulmonary surfactant proteins and retroviral antigens in the lungs of sheep with pulmonary adenomatosis.
40. Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice.
41. Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome.
42. Amniotic fluid concentration of surfactant proteins in intra-amniotic infection.
43. Novel surfactant proteins are involved in the structure and stability of foam nests from the frog Leptodactylus vastus.
44. Immunohistochemical localisation of surfactant proteins A and D, and KL-6 in pulmonary alveolar proteinosis.
45. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha.
46. Hypobaric hypoxia-related impairment of pulmonary surfactant proteins A and D did not favour Pneumocystis carinii Frenkel 1999 growth in non-immunocompromised rats.
47. Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic inflammatory airway disease.
48. Surfactant proteins in inflammatory skin diseases: controlled study.
49. Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome.
50. Genetic polymorphisms in the surfactant proteins in systemic sclerosis in Japanese: T/T genotype at 1580 C/T (Thr131Ile) in the SP-B gene reduces the risk of interstitial lung disease.
51. Presence and subcellular localizations of surfactant proteins A and D in human spermatozoa.
52. Characterization of bovine surfactant proteins B and C by electrospray ionization mass spectrometry.
53. Detection and localization of the hydrophobic surfactant proteins B and C in human tear fluid and the human lacrimal system.
54. Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D.
55. Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system.
56. Effects of hydrophobic surfactant proteins on collapse of pulmonary surfactant monolayers.
57. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease.
58. Genetic disorders of surfactant proteins.
59. Hydrophobic surfactant proteins and their analogues.
60. DNA methylation markers of surfactant proteins in lung cancer.
61. Structural and functional differences among human surfactant proteins SP-A1, SP-A2 and co-expressed SP-A1/SP-A2: role of supratrimeric oligomerization.
62. Evolution of the lung surfactant proteins in birds and mammals.
63. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis.
64. Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia.
65. Expression and localization of surfactant proteins in human nasal epithelium.
66. Potential of lung surfactant proteins, SP-A and SP-D, and mannan binding lectin for therapy and genetic predisposition to allergic and invasive aspergillosis.
67. Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions.
68. Surfactant proteins A and D in the genital tract of mares.
69. Spatial and temporal expression of surfactant proteins in hyperoxia-induced neonatal rat lung injury.
70. Expression of select immune genes (surfactant proteins A and D, sheep beta defensin 1, and toll-like receptor 4) by respiratory epithelia is developmentally regulated in the preterm neonatal lamb.
71. Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases.
72. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.
73. Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C.
74. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D.
75. Pulmonary surfactant proteins and lipids as modulators of inflammation and innate immunity.
76. Surfactant proteins SP-A and SP-D in human health and disease.
77. Surfactant proteins SP-A and SP-D: structure, function and receptors.
78. Surfactant proteins in innate host defense of the lung.
79. Distribution of surfactant proteins in type II pneumocytes of newborn, 14-day old, and adult rats: an immunoelectron microscopic and stereological study.
80. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia.
81. Antimicrobial peptides and surfactant proteins in ruminant respiratory tract disease.
82. Surface properties of sulfur- and ether-linked phosphonolipids with and without purified hydrophobic lung surfactant proteins.
83. Genetics of acute respiratory distress syndrome: challenges, approaches, surfactant proteins as candidate genes.
84. Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease.
85. Shared mechanisms of lung injury and subsequent fibrosis: role of surfactant proteins in the pathogenesis of interstitial pneumonia in Hermansky-Pudlak Syndrome.
86. Interactions between LPS and lung surfactant proteins.
87. Decrease of the surface fraction of surfactant proteins containing clara cells and type II pneumocytes in a rat asthma model.
88. Cell-specific modulation of surfactant proteins by ambroxol treatment.
89. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
90. Immunoregulatory functions of surfactant proteins.
91. Pulmonary surfactant proteins (SP-A, SP-D).
92. Coccidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)-A and SP-D.
93. Surfactant proteins and inflammation: the yin and the yang.
94. Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions.
95. Surfactant proteins in pulmonary alveolar proteinosis in adults.
96. Respiratory diseases associated to surfactant proteins B and C deficiency.
97. Comparison of the effect of ambroxol and dexamethasone on the expression of pulmonary surfactant proteins in the fetal rat lungs.
98. Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16.
99. Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin.
100. Type-II pneumocyte differentiation in pulmonary sclerosing hemangioma: ultrastructural differentiation and immunohistochemical distribution of lineage-specific transcription factors (TTF-1, HNF-3 alpha, and HNF-3 beta) and surfactant proteins.
101. Surfactant proteins A and D enhance the phagocytosis of Chlamydia into THP-1 cells.
102. Immunodetection of surfactant proteins in human organ of Corti, Eustachian tube and kidney.
103. Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins.
104. Inflammatory and anti-inflammatory responsiveness of surfactant proteins in fetal and neonatal rabbit lung.
105. Non-cooperative effects of lung surfactant proteins on early adsorption to an air/water interface.
106. Surfactant proteins SP-A and SP-D as modulators of the allergic inflammation in asthma.
107. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability.
108. Surfactant proteins A and D: major factors of the immune response of the lung.
109. Pseudomonas aeruginosa elastase degrades surfactant proteins A and D.
110. Hyperoxia and nitric oxide reduce surfactant components (DSPC and surfactant proteins) and increase apoptosis in adult and fetal rat type II pneumocytes.
111. Pulmonary surfactant proteins A and D recognize lipid ligands on Mycoplasma pneumoniae and markedly augment the innate immune response to the organism.
112. Effects of oligomerization and secondary structure on the surface behavior of pulmonary surfactant proteins SP-B and SP-C.
113. Prognostic value of surfactant proteins A and D in patients with acute lung injury.
114. Surfactant proteins and genetic predisposition to respiratory distress syndrome.
115. Surfactant proteins: role in lung physiology and disease in early life.
116. Effect of hydrophobic surfactant proteins SP-B and SP-C on binary phospholipid monolayers: II. Infrared external reflectance-absorption spectroscopy.
117. Surfactant proteins in bronchoalveolar lavage fluid of horses: assay technique and changes following road transport.
118. Hydrophobic surfactant proteins in lung function and disease.
119. Surfactant proteins as genetic determinants of multifactorial pulmonary diseases.
120. Pulmonary surfactant proteins A and D directly suppress CD3+/CD4+ cell function: evidence for two shared mechanisms.
121. Protective roles of pulmonary surfactant proteins, SP-A and SP-D, against lung allergy and infection caused by Aspergillus fumigatus.
122. Expression of surfactant proteins and thyroid transcription factor 1 in an ovine model of congenital diaphragmatic hernia.
123. Expression of epidermal growth factor and surfactant proteins during postnatal and compensatory lung growth.
124. Effect of hydrophobic surfactant proteins SP-B and SP-C on phospholipid monolayers. Protein structure studied using 2D IR and beta correlation analysis.
125. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex.
126. Tissue distribution of surfactant proteins A and D in the mouse.
127. Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C.
128. Surfactant proteins A and D in children with pulmonary disease due to gastroesophageal reflux.
129. Alveolar type II cells expressing jaagsiekte sheep retrovirus capsid protein and surfactant proteins are the predominant neoplastic cell type in ovine pulmonary adenocarcinoma.
130. Newly discovered association between lung disease and surfactant proteins.
131. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
132. Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung.
133. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
134. Decreased surfactant proteins in lambs with pulmonary hypertension secondary to increased blood flow.
135. High-yield purification of lung surfactant proteins sp-b and sp-c and the effects on surface activity.
136. Thermodynamic effects of the hydrophobic surfactant proteins on the early adsorption of pulmonary surfactant.
137. Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C.
138. Surfactant proteins A and D in Eustachian tube epithelium.
139. Structure, function, and expression of pulmonary surfactant proteins; considerations for use in artificial surfactants. Part I. Introduction.
140. Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia.
141. Expression of thyroid transcription factor-1, surfactant proteins, type I cell-associated antigen, and Clara cell secretory protein in pulmonary hypoplasia.
142. Re-expression of pulmonary surfactant proteins following tracheal obstruction in fetal sheep.
143. Interaction of lung surfactant proteins with anionic phospholipids.
144. Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis.
145. Clinical significance of serum pulmonary surfactant proteins a and d for the early detection of radiation pneumonitis.
146. Surface activity in vitro: role of surfactant proteins.
147. Surfactant proteins in the digestive tract, mesentery, and other organs: evolutionary significance.
148. Surfactant proteins and cell markers in the respiratory epithelium of the amphibian, Ambystoma mexicanum.
149. Allergen-induced bronchial inflammation is associated with decreased levels of surfactant proteins A and D in a murine model of asthma.
150. Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability.
151. Surfactant proteins D and A in sputum.
152. Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus.
153. Effect of the hydrophobic surfactant proteins on the surface activity of spread films in the captive bubble surfactometer.
154. Function of surfactant proteins B and C.
155. Surfactant proteins a and d and pulmonary host defense.
156. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens.
157. Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons.
158. Intra-amniotic endotoxin increases pulmonary surfactant proteins and induces SP-B processing in fetal sheep.
159. The role of surfactant proteins in DPPC enrichment of surface films.
160. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome.
161. Pulmonary surfactant proteins insert cation-permeable channels in planar bilayers.
162. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.
163. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury.
164. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.
165. Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia.
166. Lung surfactant proteins A and D in innate immune defense.
167. Surfactant proteins A and D bind CD14 by different mechanisms.
168. Quantitative analysis of hydrophobic pulmonary surfactant proteins by high-performance liquid chromatography with light-scattering detection.
169. The roles of surfactant proteins A and D in innate immunity.
170. Degree of lung maturity determines the direction of the interleukin-1- induced effect on the expression of surfactant proteins.
171. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.
172. Lung surfactant proteins (SP-A and SP-D) in non-adaptive host responses to infection.
173. Pulmonary surfactant proteins SP-A and SP-D.
174. Surfactant proteins A and D in premature baboons with chronic lung injury (Bronchopulmonary dysplasia). Evidence for an inhibition of secretion.
175. Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia.
176. Ultrastructure of phospholipid mixtures reconstituted with surfactant proteins B and D.
177. Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability.
178. Lung surfactant proteins involved in innate immunity.
179. Glucose decreases steady state mRNA content of hydrophobic surfactant proteins B and C in fetal rat lung explants.
180. SP-A as a cytokine: surfactant protein-A-regulated transcription of surfactant proteins and other genes.
181. Hydrophobic lung surfactant proteins B and C remain associated with surface film during dynamic cyclic area changes.
182. Effects of pulmonary surfactant proteins SP-B and SP-C and calcium ions on the surface properties of hydrophobic fractions of lung surfactant.
183. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages.
184. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
185. A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid.
186. Clearance of Clara cell secretory protein 16 (CC16) and surfactant proteins A and B from blood in acute respiratory failure.
187. Surfactant proteins A and D: disease markers.
188. Genetics of the hydrophobic surfactant proteins.
189. Genetics of the hydrophilic surfactant proteins A and D.
190. Interfacial properties of surfactant proteins.
191. Synthesis, processing and secretion of surfactant proteins B and C.
192. Functional roles of the lung surfactant proteins SP-A and SP-D in innate immunity.
193. Human surfactant proteins A1 and A2 are differentially regulated during development and by soluble factors.
194. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma.
195. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria.
196. Pulmonary surfactant proteins: structure, function, pathophysiology.
197. Method of purification affects some interfacial properties of pulmonary surfactant proteins B and C and their mixtures with dipalmitoylphosphatidylcholine.
198. Synthetic mimics of surfactant proteins B and C: in vitro surface activity and effects on lung compliance in two animal models of surfactant deficiency.
199. Surfactant proteins: molecular genetics of neonatal pulmonary diseases.
200. Regulation of surfactant proteins A and B by TNF-alpha and phorbol ester independent of NF-kappa B.
201. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis.
202. Effects of surfactant proteins SP-B and SP-C on dynamic and static mechanics of immature lungs.
203. Pulmonary surfactant proteins A and D are involved in the early response to intratracheally aerosolized lipopolysaccharide.
204. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins.
205. Expression of hydrophilic surfactant proteins by mesentery cells in rat and man.
206. Exudative lung injury is associated with decreased levels of surfactant proteins in a rat model of meconium aspiration.
207. Effects of proteinosis surfactant proteins on the viability of rat alveolar macrophages.
208. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils.
209. Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure.
210. Reverse-phase HPLC of the hydrophobic pulmonary surfactant proteins: detection of a surfactant protein C isoform containing Nepsilon-palmitoyl-lysine.
211. Transcriptional regulation of surfactant proteins SP-A and SP-B by phorbol ester.
212. TGF-beta 3 inhibits the increased gene expressions of pulmonary surfactant proteins induced by dexamethasone in fetal rat lung in vitro.
213. What NMR can tell us about where lung surfactant proteins live.
214. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages.
215. Combinations of fluorescently labeled pulmonary surfactant proteins SP-B and SP-C in phospholipid films.
216. Surfactant proteins and stable microbubbles in tracheal aspirates of infants with respiratory distress syndrome: relation to the degree of respiratory failure and response to exogenous surfactant.
217. Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia.
218. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens.
219. Alteration of pulmonary surfactant proteins in rats chronically exposed to cigarette smoke.
220. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide.
221. Differential activity and lack of synergy of lung surfactant proteins SP-B and SP-C in interactions with phospholipids.
222. Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro.
223. The expression of pulmonary surfactant proteins B and surfactant protein C in E. coli.
224. Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse.
225. Transcriptional regulation of human pulmonary surfactant proteins SP-B and SP-C by glucocorticoids.
226. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
227. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers.
228. Expression and distribution of surfactant proteins and lysozyme after prolonged hyperpnea.
229. Proliferation of alveolar epithelial cells and gene expression of surfactant proteins in adult respiratory distress syndrome (ARDS).
230. Quantitative analysis of pulmonary surfactant proteins B and C.
231. External reflection absorption infrared spectroscopy study of lung surfactant proteins SP-B and SP-C in phospholipid monolayers at the air/water interface.
232. Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages.
233. Calcium ions and interactions of pulmonary surfactant proteins SP-B and SP-C with phospholipids in spread monolayers at the air/water interface.
234. Interactions of hydrophobic lung surfactant proteins SP-B and SP-C with dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol bilayers studied by electron spin resonance spectroscopy.
235. Conformational flexibility of pulmonary surfactant proteins SP-B and SP-C, studied in aqueous organic solvents.
236. Functions of the surfactant proteins: a perspective.
237. Potential role of surfactant proteins A and D in innate lung defense against pathogens.
238. Dynamic surface properties of pulmonary surfactant proteins SP-B and SP-C and their mixtures with dipalmitoylphosphatidylcholine.
239. Chimeras of surfactant proteins A and D identify the carbohydrate recognition domains as essential for phospholipid interaction.
240. Pulmonary surfactant proteins.
241. Ontogeny of surfactant proteins and lipid-synthesizing enzymes in cultured fetal lung epithelial cells.
242. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: III. Proteins SP-B plus SP-C with phospholipids in spread monolayers.
243. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: II. Monolayers of pulmonary surfactant protein SP-C and phospholipids.
244. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: I. Monolayers of pulmonary surfactant protein SP-B and phospholipids.
245. Surfactant proteins A and D.
246. Expression of surfactant proteins in embryonic rat lung.
247. Surfactant proteins A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in the fetal membranes.
248. Lipid binding properties of lung specific C-type lectins, pulmonary surfactant proteins SP-A and SP-D.
249. Biosynthetic routing of pulmonary surfactant proteins in alveolar type II cells.
250. Pulmonary surfactant proteins.
251. Pre-translational regulation of lipid synthesizing enzymes and surfactant proteins in fetal rat lung in explant culture.
252. Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum.
253. Solubility of hydrophobic surfactant proteins in organic solvent/water mixtures. Structural studies on SP-B and SP-C in aqueous organic solvents and lipids.
254. Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits.
255. Differential glucocorticoid regulation of the pulmonary hydrophobic surfactant proteins SP-B and SP-C.
256. Lung surfactant proteins, SP-B and SP-C, alter the thermodynamic properties of phospholipid membranes: a differential calorimetry study.
257. Biochemical and clinical aspects of pulmonary surfactant proteins.
258. Surfactant proteins and lipids are regulated independently during hyperoxia.
259. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity.
260. Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C.
261. Identical and similar amino acid sequences in the pulmonary surfactant proteins SP-B and SP-C and hemerythrin and myohemerythrin--an example of "biochemical Velcro"?
262. Localization of pulmonary surfactant proteins using immunohistochemistry and tissue in situ hybridization.
263. Interaction of lipid vesicles with monomolecular layers containing lung surfactant proteins SP-B or SP-C.
264. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment.
265. In vivo regulation of surfactant proteins by glucocorticoids.
266. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C.
267. Surfactant proteins and SP-D.
268. Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C.
269. Increased expression of pulmonary surfactant proteins in oxygen-exposed rats.
270. Appearance of surfactant proteins, SP-A and SP-B, in developing rat lung and the effects of in vivo dexamethasone treatment.
271. The utility of postmortem lung for RNA studies; variability and correlation of the expression of surfactant proteins in human lung.
272. Strategies for analysis of gene expression: pulmonary surfactant proteins.
273. Structure-function relationships of bovine pulmonary surfactant proteins: SP-B and SP-C.
274. Staining properties of bovine low molecular weight hydrophobic surfactant proteins after polyacrylamide gel electrophoresis.
275. Surfactant proteins in the diagnosis of fetal lung maturity. II. The 35 kd protein and phospholipids in complicated pregnancy.
276. Synthetic amphipathic sequences of surfactant protein-B mimic several physicochemical and in vivo properties of native pulmonary surfactant proteins.
277. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung.
278. Pulmonary surfactant in fetuses and newborn infants. Metabolic maturation of pneumocytes and the role of surfactant proteins.
279. CP4: a pneumocyte-derived collagenous surfactant-associated protein. Evidence for heterogeneity of collagenous surfactant proteins.
280. Structure and function of pulmonary surfactant proteins.
281. Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line.
282. Mixtures of low molecular weight surfactant proteins and dipalmitoyl phosphatidylcholine duplicate effects of pulmonary surfactant in vitro and in vivo.
283. Surfactant proteins in the diagnosis of fetal lung maturity. I. Predictive accuracy of the 35 kD protein, the lecithin/sphingomyelin ratio, and phosphatidylglycerol.
284. Monoclonal antibodies to surfactant proteins SP28-36 label canine type II and nonciliated bronchiolar cells by immunofluorescence.
285. Electron microscopic demonstration of pulmonary surfactant proteins using procion brilliant blue H5GS.